162 related articles for article (PubMed ID: 18269583)
1. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule.
Chetty R; Serra S
Histopathology; 2008 Feb; 52(3):325-30. PubMed ID: 18269583
[TBL] [Abstract][Full Text] [Related]
2. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
[TBL] [Abstract][Full Text] [Related]
3. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
4. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
[TBL] [Abstract][Full Text] [Related]
7. Nuclear E-cadherin immunoexpression: from biology to potential applications in diagnostic pathology.
Chetty R; Serra S
Adv Anat Pathol; 2008 Jul; 15(4):234-40. PubMed ID: 18580099
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
9. Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.
Hav M; Lem D; Chhut SV; Kong R; Pauwels P; Cuvelier C; Piet P
Malays J Pathol; 2009 Dec; 31(2):137-41. PubMed ID: 20514858
[TBL] [Abstract][Full Text] [Related]
10. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas.
Audard V; Cavard C; Richa H; Infante M; Couvelard A; Sauvanet A; Terris B; Paye F; Flejou JF
Pancreas; 2008 Jan; 36(1):80-3. PubMed ID: 18192886
[TBL] [Abstract][Full Text] [Related]
11. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
[TBL] [Abstract][Full Text] [Related]
13. Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas.
Serra S; Chetty R
J Clin Pathol; 2008 Nov; 61(11):1153-9. PubMed ID: 18708424
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
16. Changes in immunoexpression of E-cadherin and beta-catenin in oral squamous cell carcinoma with and without nodal metastasis.
Lopes FF; da Costa Miguel MC; Pereira AL; da Cruz MC; de Almeida Freitas R; Pinto LP; de Souza LB
Ann Diagn Pathol; 2009 Feb; 13(1):22-9. PubMed ID: 19118778
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
Ramburan A; Hadley GP; Govender D
Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
[TBL] [Abstract][Full Text] [Related]
18. The clear cell variant of solid pseudopapillary tumor of the pancreas: a previously unrecognized pancreatic neoplasm.
Albores-Saavedra J; Simpson KW; Bilello SJ
Am J Surg Pathol; 2006 Oct; 30(10):1237-42. PubMed ID: 17001153
[TBL] [Abstract][Full Text] [Related]
19. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Alexiou D; Kalahanis N; Rosenberg T; Bastounis E
Anticancer Res; 1998; 18(6A):4177-80. PubMed ID: 9891464
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
Min Kim S; Sun CD; Park KC; Kim HG; Lee WJ; Choi SH
J Surg Oncol; 2006 Oct; 94(5):418-25. PubMed ID: 16967453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]